Kingfisher Announces FDA 510(k) Clearance Of Breakthrough KFH Energy For Chronic Pain Sufferers

Kingfisher Americas, a healthcare company focused on improving patient quality of life, announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market KFH Energy in the United States. The patented, high-tech medical device is intended to improve upon quality of life for sufferers of chronic pain associated with post-polio syndrome, fibromyalgia, multiple sclerosis, and chronic fatigue syndrome.

More: continued here

Filed under: Pain / Anesthetics on April 2nd, 2008